AzTrials
AzTrials

Parkinson's DiseaseNCT06390553

Effect of Virtual Reality on Freezing Phenomenon, Balance, Functional Mobility, Participation in Parkinson's Patients

A study testing Task-Oriented Virtual Reality Application with Crowd Simulation and Conventional Parkinson Rehabilitation in people with Parkinson's Disease and Freezing of Gait, run by Ankara Yildirim Beyazıt University at 3 sites in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study was planned to investigate the use and results of virtual reality applications with specially prepared software for the rehabilitation of freezing phenomenon, which increases the falling anxiety of individuals with Parkinson's disease and causes social isolation. Read more about this study

Who is it for?
Ages 50 years and older
Conditions the study is for
Parkinson's Disease, Freezing of Gait
What is being tested?
Task-Oriented Virtual Reality Application with Crowd Simulation and Conventional Parkinson Rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
3 sitesTurkey (Türkiye)
Study dates
Aug 2024to Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Being diagnosed with Parkinson's disease by a qualified neurologist (diagnosed with idiopathic PD according to UK Brain Bank criteria
  • Being between 1-2.5 stages according to the Hoehn and Yahr Staging Scale
  • Volunteering to participate in the study
  • 50 years of age or older
  • Standardized Mini Mental Test score greater than 24
  • Patients experiencing an on-off period are in the "on" period
Show all 9Show fewer
  • Not using deep brain stimulation or drug pump
  • Ability to walk independently on level ground (Functional Ambulation 3 and above according to classification)
  • Having a score of (≥2) on item 3 of the freezing while walking scale

Who cannot join

  • Being any neurological or psychiatric disease other than Parkinson's disease
  • Cardiovascular, vestibular or musculoskeletal disease
  • Dyskinetic movements
  • Having vision problems that cannot be corrected with glasses or lenses
  • Hearing problems that cannot be corrected with a hearing aid
  • Using an assistive device

Trial locations and contacts

3 sites in 1 country.

Ertuğrul DEMİRDEL, Assoc. Prof. contact

+903129061928

edemirdel@aybu.edu.tr

Özge BARUT ÇELİK, MSc. contact

+905527521401

ozgebarut@ahievran.edu.tr

Turkey (Türkiye)3 sites
  • Gazi University

    Ankara, Maltepe, 06570

    ÖNER BARUT, Asst. Prof., +903125823277, onerbarut@gazi.edu.tr

    ÖNER BARUT, Asst. Prof

  • Ankara Yildirim Beyazit University

    Ankara, Çubuk, 06760

    ERTUĞRUL ERTUĞRUL, Assoc. Prof., +903129061928, edemirdel@aybu.edu.tr

    ERTUĞRUL ERTUĞRUL, Assoc. Prof

  • Kirsehir Ahi Evran University

    Kirşehi̇r, Merkez, 40100

    ÖZGE BARUT ÇELİK, MSc, +905527521401, ozgebarut@ahievran.edu.tr

    Özge BARUT ÇELİK, MSc.

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Task-Oriented Virtual Reality Access With Crowd Simulation on Freezing Phenomenon, Balance, Functional Mobility, Participation and Quality of Life in Parkinson's Patients

This study was planned to investigate the use and results of virtual reality applications with specially prepared software for the rehabilitation of freezing phenomenon, which increases the falling anxiety of individuals with Parkinson's disease and causes social isolation. Individuals over the age of 50 who have been diagnosed with idiopathic Parkinson's disease by a specialist neurologist will be included in the study; Individuals evaluated in terms of balance, functional mobility, freezing phenomenon, participation, and cognitive status will be randomly divided into two groups receiving conventional treatment and additional virtual reality. After the preliminary evaluation, they will receive 8 weeks of treatment 4 days a week and will be evaluated after the treatment and 3 months after the treatment. In addition to the improvements that will emerge as a result of the treatments within the scope of the study, it is expected that the virtual reality application created with crowd simulation will provide more effective results in improving the parameters. Knowing the effects of exercises in crowds, which cannot be performed in the clinic, in the treatment of Parkinson's disease patients, whose freezing and freezing-related symptoms are aggravated, especially in crowded environments, will make significant contributions to the field.

Being tested
Task-Oriented Virtual Reality Application with Crowd Simulation, Conventional Parkinson Rehabilitation
Keywords
virtual reality, rehabilitation
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Task-Oriented Virtual Reality Application with Crowd SimulationDevice

    Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.

  • Conventional Parkinson RehabilitationProcedure or surgery

    Patients will be treated 4 days a week for 8 weeks in accordance with their assigned group.

Study groups in NCT06390553
Study groupRoleWhat they receive
Conventional groupActive comparatorPatients in the conventional treatment group will be given 15 minutes of walking training in addition to the 45 minutes of conventional Parkinson's rehabilitation program. Patients in the conventional treatment group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors), stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Walking training to be given to the conventional group will include walking in different directions, walking with arm swing, walking over blocks, stopping and restarting walking, and changing direction activities.
Receives: Procedure: Conventional Parkinson Rehabilitation
Virtual reality groupExperimentalPatients in the virtual reality group will be given a 45-minute conventional Parkinson's rehabilitation program similar to those in the conventional group, followed by 15 minutes of virtual reality walking training. Patients in the virtual reality group will be trained in flexibility (lumbar extensors, hip flexors, hamstrings, pectorals), balance (weight transfer, static balance with stress loading) coordination (rotational and bilateral activities), Respiratory (thoracic expansion, respiratory control), strength (hip circumference, abdomen, back extensors) stabilization, posture (chin tuck, scapular adduction) exercises will be given and the number of repetitions will be adjusted according to patient performance. Virtual reality applications increase the sense of reality in the individual with enriched virtual environments where sensory inputs are increased and provide the opportunity to perform activity training with a rich variety of tasks.
Receives: Device: Task-Oriented Virtual Reality Application with Crowd Simulation; Procedure: Conventional Parkinson Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Freezing Phenomenon

    The presence and severity of freezing in patients will be evaluated with the Freezing of Gait Questionnaire. It consists of six items and each item is evaluated with a 5-point Likert scale. In the scale, which was adapted into Turkish by Candan et al., the score range is 0-24 and high scores indicate that the condition associated with frostbite is poor.

    Measured: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  2. Balance

    The balance of the patients will be evaluated with the Biodex Balance System. Postural stability and fall risk will be evaluated.

    Measured: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  3. Functional Mobility

    The Timed Get Up and Go Test (TUG) will be used to assess functional mobility. The TUG, which includes walking and turning functions, has been shown to be highly reliable and valid for individuals with Parkinson's disease). The person to be tested sits on a chair at normal height. With the command "Go", the person is asked to get up from the chair and walk 3 m forward at a normal walking speed and then return and sit back on the chair. It is usually administered twice and the average time is recorded. The person is allowed to use an assistive device (if available) and this is noted.

    Measured: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  4. Quality of Life Assessment

    Quality of life will be assessed with Parkinson's Disease Questionnaire (PDQ-8) developed specifically for individuals with Parkinson's disease. This validated questionnaire consists of eight questions to assess mobility, activities of daily living, emotional well-being, disease stigma, social support, cognition, communication and physical discomfort . In the questionnaire, the status of the person in the last month is questioned. The total score is between 0 and 100, with lower scores indicating better perceived health status due to the disease.

    Measured: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  5. Participation

    In order to evaluate social participation in the study, home participation (grocery shopping, meal preparation, daily household chores, money management, etc.), social participation (hobby, going out of the house, etc.), productivity (school, work, volunteer activities, etc.), electronic A scale consisting of 43 social networks (internet use, social communication, mobile phone use, etc.), 4 subunits and a total of 18 questions will be used.

    Measured: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

Secondary outcomes (2)
  1. Executive functions

    The Trail Making Test (TMT) will be used to assess executive functions. The TMT measures executive functions such as working memory, complex attention, planning and set switching and requires visual-spatial processing and motor skills. TMT , A and B It consists of two parts. Part A of the TMT, which is an executive function test, evaluates the processing speed based on visual scanning ability, while part B evaluates the ability to change the setup between stimulus sets and to follow the sequentiality. Cangöz et al. determined the standardized values of the test for people over 50 years of age.

    Measured: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

  2. The activity-specific balance confidence scale

    The activity-specific balance confidence scale will be used to assess the level of confidence the individual feels when performing balance-related activities of daily living. In the questionnaire consisting of 16 questions, the level of confidence felt ranges from 0% (completely insecure) to 100% (completely safe). The score obtained is divided by 16 to obtain a total score. 0-49 points indicate low functional level, 50-80 points indicate medium functional level and 81-100 points indicate high functional level. Scores below 67% indicate a fall risk in elderly individuals.

    Measured: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2024
  2. Study startAug 2024 (estimated)
  3. Primary completionFeb 2026 (estimated)
  4. Study completionApr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06390553
Sponsor's protocol ID
AnkaraYBÜ-VR
Status last verified
Apr 2024
First submitted
19 Apr 2024
Last updated
30 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Task-Oriented Virtual Reality Application with Crowd Simulation and Conventional Parkinson Rehabilitation in people with Parkinson's Disease and Freezing of Gait, run by Ankara Yildirim Beyazıt University at 3 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ertuğrul DEMİRDEL, Assoc. Prof. (+903129061928, edemirdel@aybu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Freezing Phenomenon (time frame: Day 1-Study Day Visit; 8-week Follow-up Visit; 3-month Follow-up Visit). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2024; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in